Mustang Bio, Inc. (MBIO:NASDAQ) closed at $0.415 on November 2, 2026, up 3.72% on the day. The stock trades 71.4% below its 52-week high of $1.45 and 18.6% above its 52-week low of $0.350. Over the past year, it lost 70.1%. Mustang Bio, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 31, 2025, MBIO closed higher on 95 days (38%). Its best day was June 1, 2026 (+14.78%) and its worst was February 3, 2026 (-12.96%). The stock moved 10% or more in a single session 8 times.
Mustang Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells.
Find more stocks like MBIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.